期刊文献+

持续性或复发性中心性浆液性脉络膜视网膜病变的危险因素分析 被引量:2

Risk factors for persistent or recurrent central serous chorioretinopathy
下载PDF
导出
摘要 目的探讨持续性或复发性中心性浆液性脉络膜视网膜病变(CSC)的危险因素。方法回顾性分析2015年9月至2019年1月于徐州市第一人民医院收治的首次急性发作的CSC 150例(150只眼)患者的临床资料。根据患者出院后3个月内视网膜下液是否完全消退、且1年内是否复发分为观察组(持续性或复发性)和对照组(病情自限缓解)。采用多因素Logistic回归分析检验CSC持续或反复发作的危险因素。结果150例CSC患者中,对照组26例,观察组126例。多因素Logistic回归分析结果显示,男性、年龄≥50岁及失眠严重指数量表(ISI)评分≥14分为持续性或复发性CSC的独立危险因素(P<0.05)。结论男性、年龄≥50岁和ISI评分≥14分是CSC持续或反复发作的的独立危险因素,缓解睡眠障碍或许能改善患者的预后。 Objective To investigate risk factors for persistent or recurrent central serous chorioretinopathy(CSC).Methods The clinical data of 150 patients with first-onset CSC admitted to the Xuzhou First People's Hospital from September 2015 to January 2019 were retrospectively analyzed.The patients were divided into the observation group(persistent or recurrent)and the control group(self-limiting remission)according to whether the subretinal fluid completely subsided within 3 months after hospital discharge and relapse within 1 year.Multiple logistic regression analysis was used to examine the risk factors for persistent or recurrent CSC.Results Among the 150 CSC patients,26 were in the control group and 126 were in the observation group.Multiple logistic regression analysis showed that male gender,age≥50 years,and ISI score≥14 were independent risk factors for persistent or recurrent CSC(P<0.05).Conclusions Male gender,age≥50 years,and ISI score≥14 are independent risk factors for persistent or recurrent CSC.Relieving sleep disorders may improve patient prognosis.
作者 丁文君 张正培 Ding Wenjun;Zhang Zhengpei(Department of Ophthalmology, Xuzhou First People's Hospital (Xuzhou Medical University Affiliated Municipal Hospital, Xuzhou Eye Disease Prevention Institute),Xuzhou 221000,China)
出处 《临床眼科杂志》 2020年第5期395-397,共3页 Journal of Clinical Ophthalmology
关键词 中心性浆液性脉络膜视网膜病变 持续 复发 危险因素 Central serous chorioretinopathy Persistence Relapse Risk factors
  • 相关文献

二级参考文献24

  • 1曹琳彰,张宏远,张永存.药物联合高压氧治疗视网膜挫伤疗效观察[J].眼外伤职业眼病杂志,2006,28(12):950-951. 被引量:3
  • 2朱丹丹,陈辉.神经生长因子及其在眼科领域的应用[J].中国实用眼科杂志,2007,25(9):942-944. 被引量:2
  • 3Ross A,Ross AHfMohamed Q.Review and update of central se- rous chorioretinopathy.Current Opinion Ophthalmol,2011,22:166-173.
  • 4Ueng SWN.,Yuan LJ.Lin SS,et al.Hypeibaric oxygen treatment prevents nitricoxide-induced apoptosis in articular caitilageinjuiy via enhancement of theexpression of heat kockprotein70.Orthopae- dicRes,2013,31:376-384.
  • 5Chang YH,Chen PL,Tai MC,et al.Hyperbaricoxygen therapy am eliorales the blood-retinal bairieibreakdown in diabetic retinopa- thy.Clin Exp Ophthalmol,2006,3:584-589.
  • 6Zhu H.Yu WJ.Le Y.et al.High glucose levels increaae the ea- presdon ctf neurotrophic factors associated with p-p42/p44 MAPK in Schwann ceils in vitro.Mol Med Report,2012,6:179-184.
  • 7Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one - year re- sults of a prospective study [ J ]. Retina, 2008,28 ( 1 ) :85 - 93.
  • 8Ruiz - Moreno JM, Lugo FL, Armada F, et al. Photodynamic therapy for chronic central serous chorioretinopathy [ J ]. Acta Ophthalmol, 2010,88 ( 3 ) :371 - 376.
  • 9Prttnte C, Flammer J. Chomidal capillary and venous congestion in central serous chorioretinopathy [ J]. Am J Ophthalmol, 1996, 121(1) :26 -34.
  • 10Sehltzer - Schrehardt U, Viestenz A, Naumann GO, et al. Dose- related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes [ J ]. Graefes Arch Clin Exp Ophthalmol, 2002,240(9) :748 -757.

共引文献5

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部